A detailed history of Bank Of America Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of America Corp holds 20,639,756 shares of ABBV stock, worth $3.52 Billion. This represents 0.32% of its overall portfolio holdings.

Number of Shares
20,639,756
Previous 19,724,535 4.64%
Holding current value
$3.52 Billion
Previous $3.59 Billion 1.44%
% of portfolio
0.32%
Previous 0.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $142 Million - $165 Million
915,221 Added 4.64%
20,639,756 $3.54 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $180 Million - $205 Million
1,124,582 Added 6.05%
19,724,535 $3.59 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $47.3 Million - $53.3 Million
343,773 Added 1.88%
18,599,953 $2.88 Billion
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $325 Million - $404 Million
-2,451,672 Reduced 11.84%
18,256,180 $2.46 Billion
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $105 Million - $121 Million
726,693 Added 3.64%
20,707,852 $3.3 Billion
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $10.4 Million - $12.5 Million
75,245 Added 0.38%
19,981,159 $3.23 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $154 Million - $177 Million
-1,147,545 Reduced 5.45%
19,905,914 $2.67 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $164 Million - $209 Million
1,191,947 Added 6.0%
21,053,459 $3.22 Billion
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $70.4 Million - $87.3 Million
-533,260 Reduced 2.61%
19,861,512 $3.22 Billion
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $29.8 Million - $37.7 Million
277,399 Added 1.38%
20,394,772 $2.76 Billion
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $129 Million - $147 Million
1,213,108 Added 6.42%
20,117,373 $2.17 Billion
Q2 2021

Sep 13, 2021

BUY
$105.21 - $117.21 $1.99 Billion - $2.22 Billion
18,904,265 New
18,904,265 $2.13 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.